ENTERO Vu 24% (E-Z-EM Canada Inc)
Welcome to the PulseAid listing for the ENTERO Vu 24% drug offered from E-Z-EM Canada Inc. This Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | E-Z-EM Canada Inc |
NON-PROPRIETARY NAME: | barium sulfate |
SUBSTANCE NAME: | BARIUM SULFATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | SUSPENSION |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2000-09-30 |
END MARKETING DATE: | 0000-00-00 |
ENTERO Vu 24% HUMAN PRESCRIPTION DRUG Details:
Item Description | ENTERO Vu 24% from E-Z-EM Canada Inc |
LABELER NAME: | E-Z-EM Canada Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 240(mg/mL) |
START MARKETING DATE: | 2000-09-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 32909-145_83a06a8e-93db-a59b-933c-5882127bce7c |
PRODUCT NDC: | 32909-145 |
APPLICATION NUMBER: | |
Other BARIUM SULFATE Pharmaceutical Manufacturers / Labelers: